The following interviews with kidney cancer experts discuss the latest advances in the treatment of renal cell carcinoma (RCC) and renal masses:

No OS signal in axitinib + avelumab combination therapy – Dr Toni Choueiri, Dana Faber Cancer Institute, Boston, USA

Treating renal masses with minimal invasive ablative technique – Dr Alessandro Volpe, Maggiore Della Carita Hospital, Novara, Italy

New neoadjuvant trials in kidney cancer – Dr Jose Karam, MD Anderson Cancer Center, Houston, Texas, USA

Surgery or therapy first in kidney cancer – Dr Axel Bex, The Netherlands Cancer Institute, Amsterdam